Ashwin N. Ananthakrishnan, Ramnik J. Xavier, Daniel K. Podolsky
Inflammatory Bowel Diseases (eBook, ePUB)
A Clinician's Guide
105,99 €
105,99 €
inkl. MwSt.
Sofort per Download lieferbar
0 °P sammeln
105,99 €
Als Download kaufen
105,99 €
inkl. MwSt.
Sofort per Download lieferbar
0 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
105,99 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
0 °P sammeln
Ashwin N. Ananthakrishnan, Ramnik J. Xavier, Daniel K. Podolsky
Inflammatory Bowel Diseases (eBook, ePUB)
A Clinician's Guide
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Inflammatory Bowel Diseases: A Clinician's Guide provides practical guidance for the diagnosis and management of those suspected or known to have one of the forms of these complex diseases. It is perfect both for gastroenterology trainees learning to care for these patients and the experienced physician as a concise and practical resource for day to day use. Written by the experts, Inflammatory Bowel Diseases: A Clinician's Guide is an essential tool for all gastroenterologists managing patients with inflammatory bowel disease.
- Geräte: eReader
- mit Kopierschutz
- eBook Hilfe
- Größe: 6.55MB
Andere Kunden interessierten sich auch für
- Ashwin N. AnanthakrishnanInflammatory Bowel Diseases (eBook, PDF)105,99 €
- Practical Gastroenterology and Hepatology Board Review Toolkit (eBook, ePUB)71,99 €
- Liver Transplantation (eBook, ePUB)134,99 €
- Yamada's Textbook of Gastroenterology (eBook, ePUB)396,99 €
- Yamada's Atlas of Gastroenterology (eBook, ePUB)215,99 €
- Handbook of Gastrointestinal Cancer (eBook, ePUB)63,99 €
- Irritable Bowel Syndrome (eBook, ePUB)78,99 €
-
-
-
Inflammatory Bowel Diseases: A Clinician's Guide provides practical guidance for the diagnosis and management of those suspected or known to have one of the forms of these complex diseases. It is perfect both for gastroenterology trainees learning to care for these patients and the experienced physician as a concise and practical resource for day to day use. Written by the experts, Inflammatory Bowel Diseases: A Clinician's Guide is an essential tool for all gastroenterologists managing patients with inflammatory bowel disease.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: John Wiley & Sons
- Seitenzahl: 232
- Erscheinungstermin: 2. März 2017
- Englisch
- ISBN-13: 9781119077626
- Artikelnr.: 52579442
- Verlag: John Wiley & Sons
- Seitenzahl: 232
- Erscheinungstermin: 2. März 2017
- Englisch
- ISBN-13: 9781119077626
- Artikelnr.: 52579442
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Ashwin N. Ananthakrishnan MD, MPH, Assistant Professor of Medicine, Harvard Medical School; Director, Crohn's and Colitis Center, Massachusetts General Hospital, Boston, MA, USA. Ramnik J. Xavier MD, Kurt Isselbacher Professor of Medicine, Harvard Medical School; Chief of Gastroenterology, Massachusetts General Hospital; Institute Member, Broad Institute of MIT and Harvard, Boston, MA, USA. Daniel K. Podolsky MD, President, University of Texas Southwestern Medical Center; Professor of Internal Medicine, University of Texas Southwestern Medical School, Dallas, TX, USA.
Preface
Section I Pathogenesis and Clinical Features
1 Epidemiology and Pathogenesis
Clinical Take Home Messages
Epidemiology
Pathogenesis
Genetics
Microbiome
Environmental Triggers
Case Studies and Multiple Choice Questions
References
Answers to Questions
2 Clinical Features and Diagnosis of Crohn's Disease
Clinical Take Home Messages
Clinical Features
Disease Course and Natural History
Diagnosis
History and Physical Examination
Laboratory Investigations
Serologic Markers
Endoscopy
Histology
Imaging Studies
Case Studies and Multiple Choice Questions
References
Answers to Questions
3 Clinical Features and Diagnosis of Ulcerative Colitis
Clinical Take Home Messages
Clinical Features
Disease Course and Natural History
Diagnosis
History and Physical Examination
Laboratory Investigations
Serologic Markers
Endoscopy
Histology
Imaging Studies
Differential Diagnosis (UC and CD)
Case Studies and Multiple Choice Questions
References
Answers to Questions
4 Extraintestinal Manifestations of Inflammatory Bowel Diseases
Clinical Take Home Messages
Arthritis and Arthropathy
Metabolic Bone Disease
Cutaneous Manifestations
Hepatobiliary Manifestations
Ophthalmologic Manifestations
Renal Complications
Thromboembolic and Cardiovascular Complications
Case Studies and Multiple Choice Questions
References
Answers to Questions
Section II Therapeutic Agents
5 Aminosalicylates
Clinical Take Home Messages
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Multiple Choice Questions
References
Answers to Questions
6 Corticosteroids
Clinical Take Home Messages
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Case Studies and Multiple Choice Questions
References
Answers to Questions
7 Immunomodulators
Clinical Take Home Messages
Thiopurines
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Methotrexate
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Calcineurin Inhibitors
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Case Studies and Multiple Choice Questions
References
Answers to Questions
8 Biologic Therapies
Clinical Take Home Messages
Infliximab
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Adalimumab
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Certolizumab Pegol
Efficacy in Crohn's Disease
Golimumab
Natalizumab
Vedolizumab
Newer Therapies
Case Studies and Multiple Choice Questions
References
Answers to Questions
9 Antibiotics
Clinical Take Home Messages
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Other Microbial Modification Methods - Probiotics a
Section I Pathogenesis and Clinical Features
1 Epidemiology and Pathogenesis
Clinical Take Home Messages
Epidemiology
Pathogenesis
Genetics
Microbiome
Environmental Triggers
Case Studies and Multiple Choice Questions
References
Answers to Questions
2 Clinical Features and Diagnosis of Crohn's Disease
Clinical Take Home Messages
Clinical Features
Disease Course and Natural History
Diagnosis
History and Physical Examination
Laboratory Investigations
Serologic Markers
Endoscopy
Histology
Imaging Studies
Case Studies and Multiple Choice Questions
References
Answers to Questions
3 Clinical Features and Diagnosis of Ulcerative Colitis
Clinical Take Home Messages
Clinical Features
Disease Course and Natural History
Diagnosis
History and Physical Examination
Laboratory Investigations
Serologic Markers
Endoscopy
Histology
Imaging Studies
Differential Diagnosis (UC and CD)
Case Studies and Multiple Choice Questions
References
Answers to Questions
4 Extraintestinal Manifestations of Inflammatory Bowel Diseases
Clinical Take Home Messages
Arthritis and Arthropathy
Metabolic Bone Disease
Cutaneous Manifestations
Hepatobiliary Manifestations
Ophthalmologic Manifestations
Renal Complications
Thromboembolic and Cardiovascular Complications
Case Studies and Multiple Choice Questions
References
Answers to Questions
Section II Therapeutic Agents
5 Aminosalicylates
Clinical Take Home Messages
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Multiple Choice Questions
References
Answers to Questions
6 Corticosteroids
Clinical Take Home Messages
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Case Studies and Multiple Choice Questions
References
Answers to Questions
7 Immunomodulators
Clinical Take Home Messages
Thiopurines
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Methotrexate
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Calcineurin Inhibitors
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Case Studies and Multiple Choice Questions
References
Answers to Questions
8 Biologic Therapies
Clinical Take Home Messages
Infliximab
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Adalimumab
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Certolizumab Pegol
Efficacy in Crohn's Disease
Golimumab
Natalizumab
Vedolizumab
Newer Therapies
Case Studies and Multiple Choice Questions
References
Answers to Questions
9 Antibiotics
Clinical Take Home Messages
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Other Microbial Modification Methods - Probiotics a
Preface
Section I Pathogenesis and Clinical Features
1 Epidemiology and Pathogenesis
Clinical Take Home Messages
Epidemiology
Pathogenesis
Genetics
Microbiome
Environmental Triggers
Case Studies and Multiple Choice Questions
References
Answers to Questions
2 Clinical Features and Diagnosis of Crohn's Disease
Clinical Take Home Messages
Clinical Features
Disease Course and Natural History
Diagnosis
History and Physical Examination
Laboratory Investigations
Serologic Markers
Endoscopy
Histology
Imaging Studies
Case Studies and Multiple Choice Questions
References
Answers to Questions
3 Clinical Features and Diagnosis of Ulcerative Colitis
Clinical Take Home Messages
Clinical Features
Disease Course and Natural History
Diagnosis
History and Physical Examination
Laboratory Investigations
Serologic Markers
Endoscopy
Histology
Imaging Studies
Differential Diagnosis (UC and CD)
Case Studies and Multiple Choice Questions
References
Answers to Questions
4 Extraintestinal Manifestations of Inflammatory Bowel Diseases
Clinical Take Home Messages
Arthritis and Arthropathy
Metabolic Bone Disease
Cutaneous Manifestations
Hepatobiliary Manifestations
Ophthalmologic Manifestations
Renal Complications
Thromboembolic and Cardiovascular Complications
Case Studies and Multiple Choice Questions
References
Answers to Questions
Section II Therapeutic Agents
5 Aminosalicylates
Clinical Take Home Messages
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Multiple Choice Questions
References
Answers to Questions
6 Corticosteroids
Clinical Take Home Messages
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Case Studies and Multiple Choice Questions
References
Answers to Questions
7 Immunomodulators
Clinical Take Home Messages
Thiopurines
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Methotrexate
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Calcineurin Inhibitors
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Case Studies and Multiple Choice Questions
References
Answers to Questions
8 Biologic Therapies
Clinical Take Home Messages
Infliximab
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Adalimumab
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Certolizumab Pegol
Efficacy in Crohn's Disease
Golimumab
Natalizumab
Vedolizumab
Newer Therapies
Case Studies and Multiple Choice Questions
References
Answers to Questions
9 Antibiotics
Clinical Take Home Messages
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Other Microbial Modification Methods - Probiotics a
Section I Pathogenesis and Clinical Features
1 Epidemiology and Pathogenesis
Clinical Take Home Messages
Epidemiology
Pathogenesis
Genetics
Microbiome
Environmental Triggers
Case Studies and Multiple Choice Questions
References
Answers to Questions
2 Clinical Features and Diagnosis of Crohn's Disease
Clinical Take Home Messages
Clinical Features
Disease Course and Natural History
Diagnosis
History and Physical Examination
Laboratory Investigations
Serologic Markers
Endoscopy
Histology
Imaging Studies
Case Studies and Multiple Choice Questions
References
Answers to Questions
3 Clinical Features and Diagnosis of Ulcerative Colitis
Clinical Take Home Messages
Clinical Features
Disease Course and Natural History
Diagnosis
History and Physical Examination
Laboratory Investigations
Serologic Markers
Endoscopy
Histology
Imaging Studies
Differential Diagnosis (UC and CD)
Case Studies and Multiple Choice Questions
References
Answers to Questions
4 Extraintestinal Manifestations of Inflammatory Bowel Diseases
Clinical Take Home Messages
Arthritis and Arthropathy
Metabolic Bone Disease
Cutaneous Manifestations
Hepatobiliary Manifestations
Ophthalmologic Manifestations
Renal Complications
Thromboembolic and Cardiovascular Complications
Case Studies and Multiple Choice Questions
References
Answers to Questions
Section II Therapeutic Agents
5 Aminosalicylates
Clinical Take Home Messages
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Multiple Choice Questions
References
Answers to Questions
6 Corticosteroids
Clinical Take Home Messages
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Case Studies and Multiple Choice Questions
References
Answers to Questions
7 Immunomodulators
Clinical Take Home Messages
Thiopurines
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Methotrexate
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Calcineurin Inhibitors
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Case Studies and Multiple Choice Questions
References
Answers to Questions
8 Biologic Therapies
Clinical Take Home Messages
Infliximab
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Safety
Adalimumab
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Certolizumab Pegol
Efficacy in Crohn's Disease
Golimumab
Natalizumab
Vedolizumab
Newer Therapies
Case Studies and Multiple Choice Questions
References
Answers to Questions
9 Antibiotics
Clinical Take Home Messages
Efficacy in Ulcerative Colitis
Efficacy in Crohn's Disease
Other Microbial Modification Methods - Probiotics a